Exhaustive Extractions

At iuvo, we work hard to stay on the cutting edge of new developments in testing and regulatory changes affecting the medical device and pharmaceutical industries. We will share these updates regularly here in our blog - Exhaustive Extractions.

iuvo Toxicologist Dr. Cheryl Marker Publishes Paper Related to Potential Opioid Treatment

iuvo BioScience Toxicologist Dr. Cheryl Marker was coauthor of a paper that was published in the February 2023 issue of Cell Reports entitled “A trypanosome-derived immunotherapeutics platform elicits potent high-affinity antibodies, negating the effects of the synthetic opioid fentanyl”.  Dr. Marker works in the Lumino Advisors consulting group, as part of iuvo’s consulting team. Opioid […]

Adopt a Family 2021

Due to the extreme generosity of our iuvo family, we were able to provide gifts for a mom and her five kids, along with dry food goods, and grocery store and Amazon gift cards.  Wow!!! This kindness surely has an impact.

Update from the PQRI PODP Working Group

The PQRI Parenteral and Ophthalmic Drug Product Leachables and Extractables (PODP L&E) Working Group has posted a brief update on their work to develop a risked–based approach for evaluation and safety qualification of leachables in PODPs, and Dr. Mary Richardson, iuvo’s Chief Scientific Officer, is a member of the PQRI Working Group.  The update is […]

iuvo Christmas Giving Campaign

December 21, 2020 – For the fourth year in a row, the iuvo BioScience Community Outreach Team adopted a family in need to help provide for the Christmas holiday. The family provided a wish list, and iuvo was able to give gifts to them, including several boxes of food and gift cards. Delivery was made […]

iuvo Partners to Support Regional Coronavirus Testing

September 18, 2020 – iuvo BioScience is one of two local companies partnering with Rochester Regional Health to assist with the increasing demand for coronavirus testing. There has been a shortage of Transport Media, so iuvo teamed up with the healthcare provider to produce this essential part of the test kit. “The local ecosystem that […]

FDA Issues Guidance Document on Use of ISO 10993-1

September 8, 2020 – The FDA issued a guidance document on September 4, 2020, on Use of International Standard ISO 10993-1, “Biological Evaluation of Medical Devices – Part 1: Evaluation and testing within a risk management process”.  This document is available on the FDA’s website here. This guidance document, which supersedes the 2016 version of […]

Biocompatibility for UR Biomedical Engineers

March 8, 2020 – iuvo’s Dr. Mary Richardson and Dr. Kathleen Krenzer, members of iuvo’s Lumino Advisors Consulting Group, guest-taught a class on biocompatibility to a group of biomedical engineers on Friday, March 6. The class was a graduate level class taught by Dr. Greg Gdowski at the University of Rochester’s Department of Biomedical Engineering, […]